Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic Dermatitis.

atopic dermatitis biologic therapy pediatric systemic therapy treatment

Journal

Journal of cutaneous medicine and surgery
ISSN: 1615-7109
Titre abrégé: J Cutan Med Surg
Pays: United States
ID NLM: 9614685

Informations de publication

Date de publication:
Historique:
entrez: 7 11 2019
pubmed: 7 11 2019
medline: 31 3 2020
Statut: ppublish

Résumé

Because atopic dermatitis (AD) is a chronic, relapsing disease, treatment requires the use of both active therapy to control flares and preventative maintenance therapy to promote integrity of the skin barrier. In this third of four sections, important clinical considerations for the treatment of pediatric AD are reviewed. Emerging therapies in development for pediatric AD are introduced.

Identifiants

pubmed: 31692376
doi: 10.1177/1203475419882647
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19S-31S

Auteurs

Perla Lansang (P)

Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Division of Dermatology, Faculty of Medicine, University of Toronto, ON, Canada.
Division of Paediatric Medicine, Section of Dermatology, The Hospital for Sick Children, Toronto, ON, Canada.

Joseph M Lam (JM)

Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, Canada.

Danielle Marcoux (D)

Division of Dermatology, Department of Paediatrics, Sainte-Justine University Hospital Center, University of Montreal, QC, Canada.

Vimal H Prajapati (VH)

Division of Dermatology, Department of Medicine, University of Calgary, AB, Canada.
Division of Community Pediatrics, Department of Pediatrics, University of Calgary, AB, Canada.
Division of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, AB, Canada.
Dermatology Research Institute, Calgary, AB, Canada.

Shanna Spring (S)

Division of Dermatology and Rheumatology, Children's Hospital of Eastern Ontario, Ottawa, Canada.
Department of Pediatrics, University of Ottawa, ON, Canada.
Division of Dermatology, Department of Medicine, University of Ottawa, ON, Canada.

Irene Lara-Corrales (I)

Division of Paediatric Medicine, Section of Dermatology, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Pediatrics, Faculty of Medicine, University of Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH